Australian-Canadian partnership for medical cannabis

20:00 EDT 3 Jul 2017 | Australian Life Scientist

LeafCann Group, a Melbourne-based medical cannabis producer, has formed a joint venture with Canadian developer of medical cannabis delivery systems and devices Resolve Digital Health.

The deal will grant LeafCann Group a licence to register and promote Resolve Digital Health’s proprietary Breeze Inhaler system in the Australian market. In addition, LeafCann Group and Resolve Digital Health will conduct clinical trials and pilot studies on the device and formulations in Australia.

LeafCann Group will retain an exclusive licence to sell and distribute the Breeze device for three years, with an option to extend. LeafCann Group will seek import licences for the Breeze Inhaler and pods for clinical trials and to meet demand from Australia’s Special Access Schemes, which allow for limited access to medical devices not yet registered on the Australian Register of Therapeutic Goods.

The global medical cannabis industry is estimated to reach $50 billion by 2025. In support of the growth of the industry in both Australia and Canada, LeafCann and Resolve will collaborate on a series of clinical trials that focus on symptom relief. Around the world, medical cannabis is prescribed for a plethora of medical conditions, including chronic pain, arthritis and joint disease, migraine headaches, cancer/chemotherapy, fibromyalgia, MS and many more.

“This agreement provides high-quality medical cannabis products and devices to the Australian market, to meet the needs of patients at end of life and those permitted to access medical cannabis products under Australia’s Special Access Schemes,” said LeafCann Group CEO Dr Jaroslav Boublik B.Sc.(Hons) Ph.D. (Med), MRACI, C.Chem. AACNEM, MICRS.

Original Article: Australian-Canadian partnership for medical cannabis


More From BioPortfolio on "Australian-Canadian partnership for medical cannabis"

Quick Search


Relevant Topics

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...